We’ve learned a lot from lymphocytic choriomeningitis virus—now the time has come to fight it
Key Findings: There are no vaccines or therapies available for lymphocytic choriomeningitis virus (LCMV) infection. This pathogen spreads easily and
LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved
Durable SARS-CoV-2 antibodies bind to two viral targets at once
A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks.